T3	Condition 61 71	pemphigoid
T4	Condition-Name 61 71	pemphigoid
E3	Condition:T3 Name:T4 Temporality:E7
T5	Eq-Operator 883 892	less than
A1	Eq-Operator-Value T5 LT
T6	Eq-Temporal-Unit 112 118	months
A2	Eq-Temporal-Unit-Value T6 month
T7	Eq-Temporal-Unit 895 901	months
A3	Eq-Temporal-Unit-Value T7 month
T8	Eq-Value 110 111	3
T12	Eq-Value 893 894	3
T13	Eq-Comparison 883 901	less than 3 months
E4	Eq-Comparison:T13 Operator:T5 Temporal-Unit:T7 Value:T12
T14	Eq-Comparison 318 326	received
E5	Eq-Comparison:T14 Temporal-Period:T15
T15	Eq-Temporal-Period 318 326	received
A4	Eq-Temporal-Period-Value T15 past
T16	Eq-Comparison 847 855	received
E6	Eq-Comparison:T16 Temporal-Period:T17
T17	Eq-Temporal-Period 847 855	received
A5	Eq-Temporal-Period-Value T17 past
T18	Modifier 47 60	multi-bullous
E2	Modifier:T18 Modifies:T4
T19	Eq-Comparison 100 118	more than 3 months
E7	Eq-Comparison:T19 Operator:T20 Temporal-Unit:T6 Value:T8
T20	Eq-Operator 100 109	more than
A6	Eq-Operator-Value T20 GT
T21	Drug 134 149	corticosteroids
E8	Drug:T21 Name:T22
T22	Drug-Name 134 149	corticosteroids
T23	Temporal-Connection 119 124	after
E9	Temporal-Connection:T23 Arg:E7 Arg2:E8
A7	Temporal-Connection-Type-Value E9 after
T24	Procedure 154 161	treated
E10	Procedure:T24 
R1	Treatment-For Arg1:E10 Arg2:E3	
T25	And 150 153	and
E11	And:T25 Arg:E8 Arg2:E10
T9	Insurance 409 434	national health insurance
T26	Procedure 583 592	treatment
E12	Procedure:T26 Temporality:E14
T27	Drug 565 582	anti-osteoporotic
E13	Drug:T27 Name:T28
T28	Drug-Name 565 582	anti-osteoporotic
T29	Eq-Comparison 552 561	receiving
E14	Eq-Comparison:T29 Temporal-Period:T30
T30	Eq-Temporal-Period 552 561	receiving
A8	Eq-Temporal-Period-Value T30 present
R2	Using Arg1:E12 Arg2:E13	
T10	Procedure 647 656	treatment
E15	Procedure:T10 
T31	Drug 620 637	anti-osteoporotic
E16	Drug:T31 Name:T32
T32	Drug-Name 620 637	anti-osteoporotic
T33	Assertion 607 616	requiring
E17	Assertion:T33 Asserted:E15
A9	Assertion-Type-Value E17 hypothetical
R3	Using Arg1:E15 Arg2:E16	
T34	Observation 658 665	T-score
E18	Observation:T34 Name:T35 Eq-Comparison:E19 Minimum-Count:E1
T35	Observation-Name 658 665	T-score
T36	Eq-Comparison 666 672	⩽ -3DS
E19	Eq-Comparison:T36 Operator:T37 Value:T38 Unit:T39
T37	Eq-Operator 666 667	⩽
A10	Eq-Operator-Value T37 LTEQ
T38	Eq-Value 668 670	-3
T39	Eq-Unit 670 672	DS
T1	Eq-Comparison 676 691	at least 1 site
E1	Eq-Comparison:T1 Operator:T2 Value:T11 Unit:T40
T2	Eq-Operator 676 684	at least
A11	Eq-Operator-Value T2 GTEQ
T11	Eq-Value 685 686	1
T40	Eq-Unit 687 691	site
T41	Observation 695 705	FRAX score
E20	Observation:T41 Name:T42 Eq-Comparison:E21
T42	Observation-Name 695 705	FRAX score
A12	Observation-Type-Value T35 measurement
A13	Observation-Type-Value T42 clinical-score
T43	Eq-Comparison 706 750	above the therapeutic intervention threshold
E21	Eq-Comparison:T43 Operator:T44 Unit:T45
T44	Eq-Operator 706 711	above
A14	Eq-Operator-Value T44 GT
T45	Eq-Unit 716 750	therapeutic intervention threshold
A15	Eq-Unit-Value T45 ref-range-high
T46	Or 692 694	or
E22	Or:T46 Arg:E18 Arg2:E20
T47	Condition 811 823	osteoporosis
E23	Condition:T47 Name:T48
T48	Condition-Name 811 823	osteoporosis
T49	Risk 794 798	risk
E24	Risk:T49 Risk-For:E23 Minimum-Count:E25 Severity:T53
T50	Eq-Comparison 776 787	one or more
E25	Eq-Comparison:T50 Value:T51 Operator:T52
T51	Eq-Value 776 779	one
T52	Eq-Operator 780 787	or more
A16	Eq-Operator-Value T52 GTEQ
T53	Severity 788 793	major
A17	Severity-Value T53 severe
T54	Drug 856 879	topical corticosteroids
E26	Drug:T54 Name:T55 Temporality:E6 Temporality2:E4
T55	Drug-Name 856 879	topical corticosteroids
